Kontigo Care AB (3KT) AI Stock Analysis
Kontigo Care AB
(Frankfurt:3KT)
No summary available
Kontigo Care AB (3KT) vs. iShares MSCI Germany ETF (EWG)
- Market Cap
- EUR 4.00M
- Dividend Yield
- ―
- Average Volume (3M)
- ―
- Price to Earnings (P/E)
- -42.4
- Beta (1Y)
- 0.92
- Revenue Growth
- 4.45%
- EPS Growth
- 39.53%
- Country
- Germany
- Employees
- 11
- Sector
- Healthcare
- Sector Strength
- 51
- Industry
- Medical - Healthcare Information Services
Kontigo Care AB Business Overview & Revenue Model
Company Description
Kontigo Care AB (publ) specializes in delivering healthcare solutions aimed at addressing addiction issues within Sweden. Their product portfolio includes Previct Alcohol, a digital medical device designed to manage alcohol dependence, and Previct Ga...
Kontigo Care AB Peers Comparison
Overall Rating
SE:PTRK59Neutral
SE:MNTC58Neutral
SE:SEZI57Neutral
SE:AINO41Neutral
SE:QLIFE38Underperform
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| 59Neutral | SEK 188.62M | -2.17 | ― | ― | -10.30% | -11.59% | |
| 58Neutral | SEK 435.95M | -90.48 | -3.61% | ― | 15.87% | 92.43% | |
| 57Neutral | SEK 532.17M | -5.46 | -35.44% | ― | 18.56% | 28.11% | |
| Sector * | 51Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% |
| 41Neutral | SEK 40.91M | -4.18 | 133.94% | ― | -11.53% | -53.21% | |
| 38Underperform | SEK 31.13M | -0.57 | 987.64% | ― | 226.89% | 57.26% |
* Healthcare Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| DE:3KT | Kontigo Care AB | 0.06 | -0.04 | -41.28% | |
| SE:SEZI | Senzime AB | 3.38 | -2.45 | -41.94% | |
| SE:QLIFE | Qlife Holding AB | 1.08 | -1.07 | -49.72% | |
| SE:AINO | Aino Health AB | 0.20 | 0.03 | 16.96% | |
| SE:MNTC | Mentice AB | 15.50 | 6.02 | 63.50% | |
| SE:PTRK | Physitrack Limited | 11.60 | -3.40 | -22.67% |
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.